Rifampin Injection — FDA Drug Shortage

Current — Sanofi-Aventis U.S. LLC

The FDA lists a drug shortage record for Rifampin Injection (injection) from Sanofi-Aventis U.S. LLC with status Current. The shortage was first posted on Feb 17, 2021. Reported reason: Discontinuation of the manufacture of the drug

Shortage details

Status
Current
Company
Sanofi-Aventis U.S. LLC
Package NDC
0068-0597-01
Dosage Form
Injection
Presentation
Rifadin, Injection, 600 mg (NDC 0068-0597-01)
Initial Posting
Feb 17, 2021

Reason

Discontinuation of the manufacture of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.